Patents by Inventor Edward J. Yurkow

Edward J. Yurkow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosing Regimen
    Publication number: 20090311344
    Abstract: The present invention provides a method for treating hematological disorders such as anemia and thrombocytopenia, whereby a TPO mimetic peptide compound is administered using a specified dosing regimen. The dosing regimen involves the administration of the TPO mimetic peptide compound within a specified time frame surrounding administration of a chemotherapeutic agent. The dosing regimen also involves monitoring subject response in order to determine future course of treatment.
    Type: Application
    Filed: May 29, 2009
    Publication date: December 17, 2009
    Inventors: Edward J. Yurkow, Umesh Shukla
  • TPO peptide compounds for treatment of anemia
    Patent number: 7615533
    Abstract: Peptide compounds that bind to and activate the thrombopoietin receptor (c-mpl or TPO-R) or otherwise act as a TPO agonist are disclosed.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: November 10, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Edward J. Yurkow, Brian R. MacDonald, Jeffery K. Weis
  • Use of TPO peptide compounds and pharmaceutical compostions in the treatment of anemia
    Publication number: 20080119384
    Abstract: Peptide compounds that bind to and activate the thrombopoietin receptor (c-mpl or TPO-R) or otherwise act as a TPO agonist are disclosed.
    Type: Application
    Filed: February 14, 2006
    Publication date: May 22, 2008
    Inventors: Edward J. Yurkow, Brian R. MacDonald, Jeffery K. Weis
  • Method for treating cancer
    Publication number: 20030036513
    Abstract: A method of treating lymphoma, ovarian cancer, colorectal cancer, or gastric cancer by administering an effective amount of Mesna to a patient is provided. A method for treating and reducing the effective dose of an anti-cancer agent by administering Mesna in conjunction with an anti-cancer agent is also provided.
    Type: Application
    Filed: August 26, 2002
    Publication date: February 20, 2003
    Inventors: Edward J. Yurkow, Fred H. Mermelstein